The Patent Finder

Iveric Bio, Inc.

0 patents currently held · Updated Nov 22, 2026
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Ophthotech Corporation (to 2019)

0
Ending by 2030
none
Next term end

When these terms end

Held patents by the year their term ends
2026 · 0 end2027 · 02028 · 02029 · 02030 · 0

Fee deadlines

No maintenance fee falls due on this company's record before Nov 22, 2027.

Recent changes

  • 1 term has ended since Aug 24, 2026

Patents held now

No patent on this record is in force and held under this name now.

Also on record: 4 patents in force now held by others · 8 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 7 abandoned

Showing 1 to 8 of 8, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
18/132,332ANTI-C5 Agent for Treatment of Dry Age-Related Macular Degeneration (AMD) or Geographic Atrophy Secondary to Dry AmdApr 7, 2023Abandoned
18/132,315ANTI-C5 Agent for Treatment of Dry Age-Related Macular Degeneration (AMD) or Geographic Atrophy Secondary to Dry AmdApr 7, 2023Abandoned
18/132,253Methods for Treating or Preventing Ophthalmological ConditionsApr 7, 2023Abandoned
18/107,251Method for Treating or Preventing Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)Feb 8, 2023Abandoned
17/958,710Methods for Treating or Preventing Ophthalmological ConditionsOct 3, 2022Abandoned
18/034,821Methods for Treating Ophthalmological ConditionsOct 31, 2021Pending
17/772,291ANTI-C5 Agent for Treatment of Dry Age-Related Macular Degeneration (AMD) or Geographic Atrophy Secondary to Dry AmdOct 26, 2020Abandoned
16/434,018Methods for Treating or Preventing Ophthalmological ConditionsJun 6, 2019Abandoned
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited